Acquisition by Phillip Chan of 129998 shares of Cytosorbents Crp at 0.95 subject to Rule 16b-3

CTSO Stock  USD 0.97  0.06  6.59%   
About 55% of Cytosorbents Crp's investors are presently thinking to get in. The analysis of overall sentiment of trading Cytosorbents Crp stock suggests that some investors are interested at this time. Cytosorbents Crp's investing sentiment overview a quick insight into current market opportunities from investing in Cytosorbents Crp. Many technical investors use Cytosorbents Crp stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
  
Filed transaction by Cytosorbents Crp Director, Officer: Chief Executive Officer. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Acquisition of 129998 stock option (right to buy) at 0.95 of Cytosorbents Crp by Phillip Chan on 29th of March 2024. This event was filed by Cytosorbents Crp with SEC on 2024-03-29. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Cytosorbents Crp's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Cytosorbents Crp's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Cytosorbents Crp Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Cytosorbents Crp can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Cytosorbents Crp Fundamental Analysis

We analyze Cytosorbents Crp's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Cytosorbents Crp using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Cytosorbents Crp based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Total Asset

Total Asset Comparative Analysis

Cytosorbents Crp is currently under evaluation in total asset category among its peers. Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Cytosorbents Crp Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cytosorbents Crp stock to make a market-neutral strategy. Peer analysis of Cytosorbents Crp could also be used in its relative valuation, which is a method of valuing Cytosorbents Crp by comparing valuation metrics with similar companies.

Peers

Cytosorbents Crp Related Equities

TELATela Bio   3.63   
0%
76.0%
NPCENeuropace   3.41   
0%
72.0%
FNAParagon 28   3.20   
0%
67.0%
LUNGPulmonx Corp   2.38   
0%
50.0%
KIDSOrthopediatrics Corp   2.32   
0%
49.0%
CLPTClearpoint Neuro   2.15   
0%
45.0%
OFIXOrthofix Medical   2.09   
0%
44.0%
AORTArtivion   1.62   
0%
34.0%
INGNInogen   0.83   
0%
17.0%
CVRXCVRx   0.07   
0%
1.0%
LIVNLivaNova PLC   0.04   
0%
1.0%
SRDXSurModics   0.23   
4.0%
0%
ELMDElectromed   0.90   
19.0%
0%
APYXApyx Medical   4.73   
100.0%
0%
When determining whether Cytosorbents Crp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Cytosorbents Crp's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Cytosorbents Crp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Cytosorbents Crp Stock:
Check out Cytosorbents Crp Hype Analysis, Cytosorbents Crp Correlation and Cytosorbents Crp Performance.
To learn how to invest in Cytosorbents Stock, please use our How to Invest in Cytosorbents Crp guide.
You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cytosorbents Crp. If investors know Cytosorbents will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cytosorbents Crp listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.36)
Revenue Per Share
0.72
Quarterly Revenue Growth
0.066
Return On Assets
(0.28)
Return On Equity
(1.19)
The market value of Cytosorbents Crp is measured differently than its book value, which is the value of Cytosorbents that is recorded on the company's balance sheet. Investors also form their own opinion of Cytosorbents Crp's value that differs from its market value or its book value, called intrinsic value, which is Cytosorbents Crp's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cytosorbents Crp's market value can be influenced by many factors that don't directly affect Cytosorbents Crp's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cytosorbents Crp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cytosorbents Crp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cytosorbents Crp's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.